Beijing Health (Holdings) Limited (2389) AI Stock Analysis

Beijing Health (Holdings) Limited

(HKEX:2389)

Select Model

Rating:50Neutral

Price Target:HKD 0.07▲(0.00% Upside)

Action:reiterated

Date:08/19/26

The overall score is constrained by weak financial performance, characterized by persistent losses and negative cash flow despite a relatively conservative balance sheet. Technicals provide a modest offset, with the stock in a gentle uptrend and low volatility, but this is tempered by an unattractive valuation profile driven by negative earnings and no dividend yield.

Positive Factors

Low LeverageVery low leverage reduces fixed financial obligations and preserves flexibility while the company works to improve operations. A modest debt burden can help management fund necessary initiatives, absorb volatility, and avoid the refinancing pressure that would accompany a highly leveraged balance sheet.

Negative Factors

Persistent UnprofitabilityExtremely negative operating and net margins show that the business is not currently converting revenue into sustainable earnings. Persistent losses reduce internal funding capacity, erode shareholder value over time, and make a durable recovery dependent on substantial operating improvement rather than normal growth alone.

Beijing Health (Holdings) Limited (2389) vs. iShares MSCI Hong Kong ETF (EWH)

Market Cap: HKD 448.35M
Dividend Yield: ―
Average Volume (3M): 493.52K
Price to Earnings (P/E): -4.4
Beta (1Y): 0.13
Revenue Growth: -27.63%
EPS Growth: -16.33%
Country: Hong Kong
Employees: 202
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Care Facilities

Beijing Health (Holdings) Limited Business Overview & Revenue Model

Company Description

Beijing Health (Holdings) Limited, an investment holding company, provides medical, health, and geriatric care related services and products in the People’s Republic of China. It engages in the investment and operation of general health industrial pa...

Beijing Health (Holdings) Limited Financial Statement Overview

Summary

Persistent losses, negative operating results, and weak, volatile cash flows significantly outweigh the benefit of a conservative, low-leverage balance sheet.

Income Statement

22Negative

Balance Sheet

55Neutral

Cash Flow

18Very Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	110.89M	157.20M	149.94M	140.35M	166.48M	203.78M
Gross Profit	17.21M	42.45M	35.68M	38.47M	46.51M	46.99M
EBITDA	-47.76M	-77.41M	-97.47M	-44.19M	-75.25M	-10.37M
Net Income	-103.47M	-100.91M	-116.22M	-61.88M	-97.70M	-39.41M
Balance Sheet
Total Assets	2.05B	2.10B	1.95B	2.18B	2.42B	2.84B
Cash, Cash Equivalents and Short-Term Investments	220.43M	237.36M	211.08M	335.96M	440.76M	496.30M
Total Debt	31.70M	114.16M	5.65M	4.89M	32.75M	48.37M
Total Liabilities	294.41M	343.11M	209.74M	223.82M	271.77M	341.34M
Stockholders Equity	1.67B	1.66B	1.72B	1.89B	2.04B	2.29B
Cash Flow
Free Cash Flow	-58.10M	-18.02M	-42.20M	-45.10M	-12.34M	406.00K
Operating Cash Flow	-47.70M	-5.49M	-35.56M	-43.72M	-11.19M	1.99M
Investing Cash Flow	108.91M	154.75M	-33.80M	74.76M	22.77M	-227.83M
Financing Cash Flow	-135.51M	-88.80M	-5.28M	-68.40M	-17.71M	-20.46M

Beijing Health (Holdings) Limited Technical Analysis

Technical Analysis SentimentNegative

Last Price0.07

Price Trends

50DMA0.08Negative

100DMA0.08Negative

200DMA0.07Negative

Market Momentum

MACD-0.00Negative

RSI43.35Neutral

STOCH37.50Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2389, the sentiment is Negative. The current price of 0.07 is above the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.08, and above the 200-day MA of 0.07, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 43.35 is Neutral, neither overbought nor oversold. The STOCH value of 37.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2389.

Beijing Health (Holdings) Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

HK:2389 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HK:6078	66Neutral	HKD 5.84B	27.75	2.55%	―	1.59%	-58.55%
HK:3869	54Neutral	HKD 467.79M	-143.32	-0.41%	―	3.16%	-101.02%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
HK:2389	50Neutral	HKD 448.35M	-4.35	-6.22%	―	-27.63%	-16.33%
HK:0722	42Neutral	HKD 292.35M	-3.79	-10.76%	9.04%	-1.37%	-334.69%
HK:3886	41Neutral	HKD 1.10B	78.09	0.48%	1.10%	-3.26%	―

* Healthcare Sector Average

Performance Comparison

HK:2389 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
HK:2389	Beijing Health (Holdings) Limited	0.07	-0.00	-2.63%
HK:3869	Hospital Corporation of China Ltd	3.28	-2.71	-45.24%
HK:3886	Town Health International Medical Group Ltd.	0.15	-0.12	-43.01%
HK:6078	Hygeia Healthcare Holdings Co., Ltd.	9.80	-3.34	-25.38%
HK:0722	UMP Healthcare Holdings Limited	0.38	-0.07	-15.35%

Beijing Health (Holdings) Limited Corporate Events

Beijing Health Widens Interim Loss as Revenue Slumps but FX Gains Ease Overall Hit

Aug 31, 2026

Beijing Health (Holdings) Limited reported a sharp decline in revenue for the six months ended 30 June 2026, with sales falling to HK$30.3 million from HK$76.6 million a year earlier and gross profit dropping to HK$3.8 million. Higher selling and dis...

Beijing Health Sets Board Meeting to Approve 2026 Interim Results and Dividend

Aug 13, 2026

Beijing Health (Holdings) Limited has scheduled a board meeting for 31 August 2026 to review and approve the group’s interim results for the six months ended 30 June 2026. The board will also consider the declaration of an interim dividend and...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 17, 2026

Beijing Health (Holdings) Limited AI Stock Analysis